Brief: Cyclopharm Says Technegas Shown To Have Key Role In COVID-19 Diagnosis & Management
24/05/2022 02:29
May 24 (Reuters) - Cyclopharm Ltd CYC.AX :
* TECHNEGAS SHOWN TO HAVE A KEY ROLE IN DIAGNOSIS AND
MANAGEMENT
OF COVID-19
* FINDINGS INCLUDED ROLE OF TECHNEGAS IN DIAGNOSIS & ONGOING
MANAGEMENT OF LONG COVID SYMPTOMS
Source text for Eikon: ID:nASX3yLR19
Further company coverage: CYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair